Eyenovia, Inc.

EYEN | NASDAQ | 6 Followers
$15.82 +49.81% $5.26
Follow
Loading...

Profile

Eyenovia, Inc. (EYEN) is a biotechnology company focused on the development and commercialization of ophthalmic drugs and technologies. The company specializes in an innovative approach to treat eye conditions such as glaucoma, myopia, and pupil dilation. Their drugs are designed to improve efficacy and reduce uncomfortable side effects associated with traditional ophthalmic medications. Eyenovia aims to provide patients and eye care professionals with better and more advanced medical solutions for eye-related issues. Investing in shares of Eyenovia, Inc. can present an attractive opportunity for investors interested in innovative medical fields with the potential to enhance the quality of life for patients with eye-related conditions.

Feed

There are no posts to show right now.
Don't have an account? Join us

Log in to Bulios


Or use email and password
Already a member? Log in

Create Bulios profile

Continue with

Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools

Menu StockBot
Tracker
Upgrade